| 0 |
DYSGLOBULINAEMIA |
3 |
0.1500 |
| 1 |
KERATOUVEITIS |
5 |
0.1351 |
| 2 |
MITOCHONDRIAL DNA DEPLETION |
3 |
0.0857 |
| 3 |
HYPERAMMONAEMIC CRISIS |
8 |
0.0748 |
| 4 |
MYOFASCITIS |
3 |
0.0361 |
| 5 |
BASAL GANGLIA STROKE |
5 |
0.0347 |
| 6 |
CARNITINE DEFICIENCY |
5 |
0.0292 |
| 7 |
ZINC DEFICIENCY |
5 |
0.0233 |
| 8 |
SEIZURE CLUSTER |
19 |
0.0229 |
| 9 |
VAGAL NERVE STIMULATOR IMPLANTATION |
6 |
0.0196 |
| 10 |
ANTICONVULSANT DRUG LEVEL ABNORMAL |
3 |
0.0170 |
| 11 |
ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE |
4 |
0.0159 |
| 12 |
CHANGE IN SEIZURE PRESENTATION |
10 |
0.0155 |
| 13 |
RETINOGRAM ABNORMAL |
4 |
0.0149 |
| 14 |
AMMONIA ABNORMAL |
6 |
0.0149 |
| 15 |
UREAPLASMA INFECTION |
6 |
0.0147 |
| 16 |
SHUNT MALFUNCTION |
4 |
0.0141 |
| 17 |
MELAS SYNDROME |
3 |
0.0139 |
| 18 |
AMINO ACID LEVEL INCREASED |
10 |
0.0135 |
| 19 |
MITRAL VALVE THICKENING |
4 |
0.0134 |
| 20 |
PACKAGING DESIGN ISSUE |
4 |
0.0122 |
| 21 |
HYPERAMMONAEMIA |
58 |
0.0116 |
| 22 |
HYPOPHOSPHATAEMIC OSTEOMALACIA |
3 |
0.0114 |
| 23 |
MITOCHONDRIAL CYTOPATHY |
5 |
0.0114 |
| 24 |
MITOCHONDRIAL TOXICITY |
9 |
0.0110 |
| 25 |
ATONIC SEIZURES |
9 |
0.0105 |
| 26 |
PRODUCT BARCODE ISSUE |
4 |
0.0104 |
| 27 |
DEFIANT BEHAVIOUR |
3 |
0.0097 |
| 28 |
INFANTILE SPASMS |
7 |
0.0097 |
| 29 |
ENTEROVIRUS INFECTION |
8 |
0.0093 |
| 30 |
UPPER RESPIRATORY TRACT INFLAMMATION |
11 |
0.0092 |
| 31 |
RHINOVIRUS INFECTION |
34 |
0.0087 |
| 32 |
PARAINFLUENZAE VIRUS INFECTION |
13 |
0.0085 |
| 33 |
ARTERIOVENOUS FISTULA SITE COMPLICATION |
5 |
0.0083 |
| 34 |
FEEDING TUBE USER |
3 |
0.0082 |
| 35 |
SPONTANEOUS HAEMATOMA |
6 |
0.0080 |
| 36 |
NECROTISING OESOPHAGITIS |
4 |
0.0080 |
| 37 |
ACETONAEMIA |
2 |
0.0079 |
| 38 |
DILATED CARDIOMYOPATHY |
8 |
0.0079 |
| 39 |
BLOOD MAGNESIUM INCREASED |
7 |
0.0078 |
| 40 |
TONIC CONVULSION |
11 |
0.0078 |
| 41 |
AMMONIA INCREASED |
39 |
0.0076 |
| 42 |
BLOOD HOMOCYSTEINE INCREASED |
3 |
0.0070 |
| 43 |
MYOCLONIC EPILEPSY |
10 |
0.0066 |
| 44 |
INSULIN-LIKE GROWTH FACTOR INCREASED |
9 |
0.0063 |
| 45 |
MAGNETIC RESONANCE IMAGING HEAD ABNORMAL |
4 |
0.0062 |
| 46 |
STARVATION |
5 |
0.0060 |
| 47 |
GASTROINTESTINAL VIRAL INFECTION |
6 |
0.0058 |
| 48 |
DERMATITIS DIAPER |
4 |
0.0057 |
| 49 |
PRODUCT PREPARATION ISSUE |
36 |
0.0055 |
| 50 |
AORTIC VALVE SCLEROSIS |
4 |
0.0055 |
| 51 |
OTITIS MEDIA ACUTE |
4 |
0.0054 |
| 52 |
SMALL FIBRE NEUROPATHY |
4 |
0.0054 |
| 53 |
BLOOD PH INCREASED |
3 |
0.0054 |
| 54 |
SERRATIA INFECTION |
4 |
0.0054 |
| 55 |
BURNOUT SYNDROME |
3 |
0.0053 |
| 56 |
TRACHEITIS |
4 |
0.0052 |
| 57 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
9 |
0.0052 |
| 58 |
METAPNEUMOVIRUS INFECTION |
4 |
0.0051 |
| 59 |
ESCHERICHIA BACTERAEMIA |
12 |
0.0051 |
| 60 |
CHOROIDAL EFFUSION |
4 |
0.0050 |
| 61 |
PULMONARY VALVE INCOMPETENCE |
7 |
0.0048 |
| 62 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED |
2 |
0.0048 |
| 63 |
GASTROSTOMY |
7 |
0.0045 |
| 64 |
AORTIC DILATATION |
5 |
0.0045 |
| 65 |
VENTRICULAR HYPOKINESIA |
14 |
0.0044 |
| 66 |
METABOLIC ENCEPHALOPATHY |
13 |
0.0043 |
| 67 |
PROPOFOL INFUSION SYNDROME |
3 |
0.0043 |
| 68 |
INCISION SITE PAIN |
5 |
0.0043 |
| 69 |
NEPHROCALCINOSIS |
5 |
0.0042 |
| 70 |
DYSLALIA |
3 |
0.0041 |
| 71 |
B-CELL TYPE ACUTE LEUKAEMIA |
3 |
0.0041 |
| 72 |
ORTHOPNOEA |
13 |
0.0041 |
| 73 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
3 |
0.0039 |
| 74 |
STATUS EPILEPTICUS |
44 |
0.0039 |
| 75 |
BILIRUBIN CONJUGATED INCREASED |
9 |
0.0038 |
| 76 |
BLOOD KETONE BODY INCREASED |
3 |
0.0038 |
| 77 |
HYPERLACTACIDAEMIA |
10 |
0.0037 |
| 78 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
14 |
0.0037 |
| 79 |
HAND-FOOT-AND-MOUTH DISEASE |
3 |
0.0036 |
| 80 |
DYSCHROMATOPSIA |
3 |
0.0036 |
| 81 |
FANCONI SYNDROME |
5 |
0.0035 |
| 82 |
BLOOD FIBRINOGEN DECREASED |
4 |
0.0035 |
| 83 |
SEIZURE |
400 |
0.0035 |
| 84 |
FOOD REFUSAL |
3 |
0.0034 |
| 85 |
STEROID DEPENDENCE |
3 |
0.0034 |
| 86 |
CARDIAC FAILURE CHRONIC |
14 |
0.0033 |
| 87 |
METABOLIC DISORDER |
19 |
0.0033 |
| 88 |
BEHAVIOUR DISORDER |
17 |
0.0031 |
| 89 |
RED BLOOD CELLS URINE POSITIVE |
3 |
0.0031 |
| 90 |
ANION GAP INCREASED |
4 |
0.0030 |
| 91 |
LYMPHOCYTIC INFILTRATION |
3 |
0.0030 |
| 92 |
VARICELLA |
7 |
0.0029 |
| 93 |
RENAL ARTERY STENOSIS |
4 |
0.0029 |
| 94 |
PERTUSSIS |
3 |
0.0029 |
| 95 |
CHRONIC FATIGUE SYNDROME |
4 |
0.0029 |
| 96 |
VASCULAR DEVICE INFECTION |
13 |
0.0029 |
| 97 |
GALLBLADDER ENLARGEMENT |
3 |
0.0028 |
| 98 |
ENTEROCOLITIS |
16 |
0.0028 |
| 99 |
ADENOVIRUS INFECTION |
8 |
0.0028 |
| 100 |
TRICUSPID VALVE INCOMPETENCE |
21 |
0.0026 |
| 101 |
HYPOPROTEINAEMIA |
5 |
0.0026 |
| 102 |
BRAIN OPERATION |
6 |
0.0026 |
| 103 |
PNEUMONIA PSEUDOMONAL |
4 |
0.0026 |
| 104 |
CARBON DIOXIDE DECREASED |
3 |
0.0026 |
| 105 |
FOLATE DEFICIENCY |
3 |
0.0026 |
| 106 |
MEAN CELL VOLUME DECREASED |
4 |
0.0026 |
| 107 |
BICYTOPENIA |
5 |
0.0025 |
| 108 |
ELECTROENCEPHALOGRAM ABNORMAL |
8 |
0.0025 |
| 109 |
DEVICE RELATED SEPSIS |
5 |
0.0025 |
| 110 |
ANTICONVULSANT DRUG LEVEL INCREASED |
4 |
0.0025 |
| 111 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
7 |
0.0024 |
| 112 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
3 |
0.0024 |
| 113 |
BRONCHIAL SECRETION RETENTION |
3 |
0.0024 |
| 114 |
NOCTURNAL DYSPNOEA |
3 |
0.0024 |
| 115 |
APPLICATION SITE WARMTH |
3 |
0.0024 |
| 116 |
DROOLING |
16 |
0.0023 |
| 117 |
RENAL TUBULAR ACIDOSIS |
5 |
0.0023 |
| 118 |
LIP INJURY |
3 |
0.0023 |
| 119 |
DRUG WITHDRAWAL CONVULSIONS |
4 |
0.0022 |
| 120 |
GENERALISED TONIC-CLONIC SEIZURE |
37 |
0.0022 |
| 121 |
GLYCOSURIA |
3 |
0.0022 |
| 122 |
CARBON DIOXIDE INCREASED |
3 |
0.0022 |
| 123 |
SIALOADENITIS |
3 |
0.0022 |
| 124 |
CONGESTIVE CARDIOMYOPATHY |
9 |
0.0022 |
| 125 |
MECHANICAL VENTILATION |
4 |
0.0021 |
| 126 |
EPILEPSY |
64 |
0.0021 |
| 127 |
NOROVIRUS INFECTION |
3 |
0.0021 |
| 128 |
OCULAR HYPERTENSION |
4 |
0.0021 |
| 129 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
3 |
0.0021 |
| 130 |
CARDIOPULMONARY FAILURE |
8 |
0.0020 |
| 131 |
HEPATIC ENCEPHALOPATHY |
19 |
0.0020 |
| 132 |
APLASIA PURE RED CELL |
7 |
0.0020 |
| 133 |
KNEE DEFORMITY |
3 |
0.0020 |
| 134 |
TACHYPNOEA |
27 |
0.0020 |
| 135 |
NEPHROGENIC SYSTEMIC FIBROSIS |
6 |
0.0020 |
| 136 |
HYPERTROPHIC CARDIOMYOPATHY |
3 |
0.0019 |
| 137 |
SCOLIOSIS |
12 |
0.0019 |
| 138 |
PRODUCT ADMINISTRATION INTERRUPTED |
15 |
0.0019 |
| 139 |
NEUROGENIC BLADDER |
4 |
0.0019 |
| 140 |
PNEUMONIA VIRAL |
6 |
0.0019 |
| 141 |
KIDNEY TRANSPLANT REJECTION |
9 |
0.0019 |
| 142 |
METABOLIC ALKALOSIS |
3 |
0.0019 |
| 143 |
HYPERPHOSPHATAEMIA |
4 |
0.0019 |
| 144 |
CLONUS |
5 |
0.0018 |
| 145 |
DEVICE RELATED INFECTION |
28 |
0.0018 |
| 146 |
TROPONIN I INCREASED |
3 |
0.0018 |
| 147 |
SEIZURE LIKE PHENOMENA |
3 |
0.0018 |
| 148 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
5 |
0.0018 |
| 149 |
PETIT MAL EPILEPSY |
9 |
0.0018 |
| 150 |
HAEMOLYTIC URAEMIC SYNDROME |
4 |
0.0017 |
| 151 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
15 |
0.0017 |
| 152 |
PARTIAL SEIZURES |
9 |
0.0017 |
| 153 |
FANCONI SYNDROME ACQUIRED |
3 |
0.0017 |
| 154 |
PRESCRIBED UNDERDOSE |
34 |
0.0017 |
| 155 |
GASTROINTESTINAL OEDEMA |
3 |
0.0017 |
| 156 |
MYOPIA |
4 |
0.0017 |
| 157 |
APPLICATION SITE DISCOMFORT |
3 |
0.0017 |
| 158 |
GASTROENTERITIS VIRAL |
30 |
0.0017 |
| 159 |
HYPERCAPNIA |
5 |
0.0017 |
| 160 |
CENTRAL VENOUS CATHETERISATION |
5 |
0.0017 |
| 161 |
STARING |
4 |
0.0017 |
| 162 |
LOBAR PNEUMONIA |
3 |
0.0016 |
| 163 |
HYPERVOLAEMIA |
8 |
0.0016 |
| 164 |
MULTIPLE-DRUG RESISTANCE |
5 |
0.0016 |
| 165 |
PROTEIN TOTAL DECREASED |
6 |
0.0016 |
| 166 |
NARCOLEPSY |
3 |
0.0016 |
| 167 |
MYELOPATHY |
3 |
0.0016 |
| 168 |
BLOOD CHLORIDE DECREASED |
4 |
0.0015 |
| 169 |
ADJUSTMENT DISORDER |
2 |
0.0015 |
| 170 |
PYELONEPHRITIS ACUTE |
3 |
0.0015 |
| 171 |
SKIN ODOUR ABNORMAL |
6 |
0.0015 |
| 172 |
OTITIS MEDIA |
5 |
0.0015 |
| 173 |
CLOSTRIDIUM DIFFICILE COLITIS |
16 |
0.0015 |
| 174 |
SKIN PAPILLOMA |
6 |
0.0015 |
| 175 |
HYPOPHOSPHATAEMIA |
11 |
0.0015 |
| 176 |
BLOOD SODIUM INCREASED |
4 |
0.0015 |
| 177 |
BRADYPNOEA |
4 |
0.0015 |
| 178 |
PNEUMONIA ASPIRATION |
37 |
0.0015 |
| 179 |
HYPERURICAEMIA |
6 |
0.0015 |
| 180 |
ACCIDENTAL POISONING |
2 |
0.0015 |
| 181 |
BODY TEMPERATURE FLUCTUATION |
3 |
0.0014 |
| 182 |
ACIDOSIS |
11 |
0.0014 |
| 183 |
BRONCHIOLITIS |
5 |
0.0014 |
| 184 |
MITRAL VALVE INCOMPETENCE |
16 |
0.0014 |
| 185 |
AORTIC VALVE INCOMPETENCE |
6 |
0.0014 |
| 186 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
3 |
0.0014 |
| 187 |
ANAEMIA MACROCYTIC |
3 |
0.0014 |
| 188 |
PROTEIN URINE PRESENT |
7 |
0.0014 |
| 189 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
7 |
0.0014 |
| 190 |
LIVER TRANSPLANT |
5 |
0.0014 |
| 191 |
BLOOD UREA INCREASED |
23 |
0.0014 |
| 192 |
AMYLASE INCREASED |
5 |
0.0014 |
| 193 |
CARDIAC FAILURE ACUTE |
9 |
0.0013 |
| 194 |
ATYPICAL PNEUMONIA |
4 |
0.0013 |
| 195 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
3 |
0.0013 |
| 196 |
PERIARTHRITIS |
3 |
0.0013 |
| 197 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
8 |
0.0013 |
| 198 |
DIASTOLIC DYSFUNCTION |
4 |
0.0013 |
| 199 |
INFUSION SITE EXTRAVASATION |
8 |
0.0013 |
| 200 |
BLOOD CREATININE DECREASED |
4 |
0.0013 |
| 201 |
BLOOD ALBUMIN DECREASED |
10 |
0.0013 |
| 202 |
STREPTOCOCCAL INFECTION |
7 |
0.0013 |
| 203 |
LACUNAR INFARCTION |
3 |
0.0013 |
| 204 |
METABOLIC ACIDOSIS |
40 |
0.0012 |
| 205 |
BREATH ODOUR |
3 |
0.0012 |
| 206 |
MYOSITIS |
11 |
0.0012 |
| 207 |
INTRAVENTRICULAR HAEMORRHAGE |
3 |
0.0012 |
| 208 |
HYPERNATRAEMIA |
6 |
0.0012 |
| 209 |
HYPOTONIA |
12 |
0.0012 |
| 210 |
HYPERPARATHYROIDISM SECONDARY |
3 |
0.0012 |
| 211 |
SPINAL PAIN |
14 |
0.0012 |
| 212 |
APPENDICITIS PERFORATED |
3 |
0.0012 |
| 213 |
BACTERAEMIA |
14 |
0.0012 |
| 214 |
SEDATION COMPLICATION |
3 |
0.0012 |
| 215 |
NEUTROPHIL COUNT INCREASED |
12 |
0.0012 |
| 216 |
APNOEA |
9 |
0.0012 |
| 217 |
STAPHYLOCOCCAL BACTERAEMIA |
5 |
0.0011 |
| 218 |
AORTIC STENOSIS |
4 |
0.0011 |
| 219 |
ALOPECIA AREATA |
2 |
0.0011 |
| 220 |
BLOOD LACTIC ACID INCREASED |
6 |
0.0011 |
| 221 |
SERUM FERRITIN INCREASED |
6 |
0.0011 |
| 222 |
WHITE BLOOD CELL DISORDER |
3 |
0.0011 |
| 223 |
PRODUCT SUPPLY ISSUE |
8 |
0.0011 |
| 224 |
DEVELOPMENTAL DELAY |
10 |
0.0011 |
| 225 |
SCREAMING |
7 |
0.0011 |
| 226 |
ASPIRATION |
12 |
0.0011 |
| 227 |
AUTISM SPECTRUM DISORDER |
6 |
0.0011 |
| 228 |
PRESCRIBED OVERDOSE |
21 |
0.0011 |
| 229 |
IRON DEFICIENCY ANAEMIA |
10 |
0.0011 |
| 230 |
MALNUTRITION |
12 |
0.0011 |
| 231 |
LUNG CONSOLIDATION |
3 |
0.0011 |
| 232 |
ENDOTRACHEAL INTUBATION |
3 |
0.0011 |
| 233 |
PULMONARY CONGESTION |
14 |
0.0011 |
| 234 |
RESPIRATORY SYMPTOM |
3 |
0.0011 |
| 235 |
ATELECTASIS |
10 |
0.0010 |
| 236 |
BLOOD PARATHYROID HORMONE INCREASED |
3 |
0.0010 |
| 237 |
LUMBAR SPINAL STENOSIS |
3 |
0.0010 |
| 238 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
29 |
0.0010 |
| 239 |
PULMONARY HAEMORRHAGE |
8 |
0.0010 |
| 240 |
STRABISMUS |
3 |
0.0010 |
| 241 |
CEREBRAL ATROPHY |
4 |
0.0010 |
| 242 |
HYPERPHAGIA |
4 |
0.0010 |
| 243 |
VARICES OESOPHAGEAL |
3 |
0.0010 |
| 244 |
VIRAL INFECTION |
33 |
0.0010 |
| 245 |
ENURESIS |
4 |
0.0010 |
| 246 |
EMERGENCY CARE |
3 |
0.0010 |
| 247 |
PNEUMONIA BACTERIAL |
9 |
0.0010 |
| 248 |
PORTAL HYPERTENSION |
3 |
0.0010 |
| 249 |
FAILURE TO THRIVE |
5 |
0.0010 |
| 250 |
GASTROENTERITIS |
14 |
0.0010 |
| 251 |
SLEEP TERROR |
4 |
0.0009 |
| 252 |
OBESITY |
15 |
0.0009 |
| 253 |
RETCHING |
20 |
0.0009 |
| 254 |
HAEMODYNAMIC INSTABILITY |
7 |
0.0009 |
| 255 |
URINE OUTPUT DECREASED |
8 |
0.0009 |
| 256 |
SUSPECTED COVID-19 |
3 |
0.0009 |
| 257 |
HIGH DENSITY LIPOPROTEIN DECREASED |
3 |
0.0009 |
| 258 |
COAGULOPATHY |
15 |
0.0009 |
| 259 |
RHINITIS ALLERGIC |
4 |
0.0009 |
| 260 |
SUDDEN CARDIAC DEATH |
3 |
0.0009 |
| 261 |
ALTERED STATE OF CONSCIOUSNESS |
19 |
0.0009 |
| 262 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
15 |
0.0009 |
| 263 |
SHOCK |
20 |
0.0009 |
| 264 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
3 |
0.0009 |
| 265 |
GRAND MAL CONVULSION |
8 |
0.0009 |
| 266 |
HEPATIC FAILURE |
26 |
0.0009 |
| 267 |
POST PROCEDURAL INFECTION |
7 |
0.0009 |
| 268 |
HYPOPHAGIA |
22 |
0.0009 |
| 269 |
PERIPHERAL SENSORY NEUROPATHY |
5 |
0.0009 |
| 270 |
ENCEPHALOPATHY |
21 |
0.0009 |
| 271 |
HYPERTRIGLYCERIDAEMIA |
5 |
0.0009 |
| 272 |
TIBIA FRACTURE |
4 |
0.0009 |
| 273 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
15 |
0.0008 |
| 274 |
HAND FRACTURE |
6 |
0.0008 |
| 275 |
SKIN ABRASION |
4 |
0.0008 |
| 276 |
HAEMORRHAGE SUBCUTANEOUS |
3 |
0.0008 |
| 277 |
SINUS TACHYCARDIA |
12 |
0.0008 |
| 278 |
MYOCLONUS |
10 |
0.0008 |
| 279 |
HYPERSOMNIA |
24 |
0.0008 |
| 280 |
HYPERLIPIDAEMIA |
10 |
0.0008 |
| 281 |
CHOLESTASIS |
16 |
0.0008 |
| 282 |
ABNORMAL BEHAVIOUR |
33 |
0.0008 |
| 283 |
BLOOD PHOSPHORUS DECREASED |
3 |
0.0008 |
| 284 |
VITAMIN D DEFICIENCY |
8 |
0.0008 |
| 285 |
FOOD INTOLERANCE |
3 |
0.0008 |
| 286 |
THROMBOCYTOSIS |
3 |
0.0008 |
| 287 |
BLOOD BILIRUBIN INCREASED |
22 |
0.0008 |
| 288 |
ILEUS |
10 |
0.0008 |
| 289 |
SECRETION DISCHARGE |
10 |
0.0008 |
| 290 |
BLOOD CALCIUM INCREASED |
7 |
0.0008 |
| 291 |
PRODUCT PRESCRIBING ERROR |
19 |
0.0008 |
| 292 |
FACE INJURY |
3 |
0.0008 |
| 293 |
EAR INFECTION |
21 |
0.0008 |
| 294 |
HEPATOCELLULAR CARCINOMA |
6 |
0.0008 |
| 295 |
LIPASE INCREASED |
6 |
0.0008 |
| 296 |
RESPIRATORY FAILURE |
57 |
0.0008 |
| 297 |
INCREASED UPPER AIRWAY SECRETION |
4 |
0.0008 |
| 298 |
HYPERBILIRUBINAEMIA |
8 |
0.0008 |
| 299 |
HYPOALBUMINAEMIA |
6 |
0.0008 |
| 300 |
RHABDOMYOLYSIS |
32 |
0.0008 |
| 301 |
HYPOXIA |
27 |
0.0008 |
| 302 |
FOOD CRAVING |
4 |
0.0008 |
| 303 |
CORONAVIRUS INFECTION |
5 |
0.0008 |
| 304 |
PRODUCT DISTRIBUTION ISSUE |
7 |
0.0008 |
| 305 |
MENINGITIS |
5 |
0.0007 |
| 306 |
MUSCLE HAEMORRHAGE |
3 |
0.0007 |
| 307 |
ADRENAL INSUFFICIENCY |
9 |
0.0007 |
| 308 |
HYPERGLYCAEMIA |
27 |
0.0007 |
| 309 |
MUSCLE DISORDER |
6 |
0.0007 |
| 310 |
WRONG PRODUCT ADMINISTERED |
5 |
0.0007 |
| 311 |
ABDOMINAL RIGIDITY |
2 |
0.0007 |
| 312 |
LYMPHOCYTE COUNT DECREASED |
13 |
0.0007 |
| 313 |
PERIPHERAL VENOUS DISEASE |
3 |
0.0007 |
| 314 |
RESPIRATORY DEPRESSION |
9 |
0.0007 |
| 315 |
TIC |
4 |
0.0007 |
| 316 |
RESPIRATORY TRACT INFECTION |
19 |
0.0007 |
| 317 |
AFFECT LABILITY |
7 |
0.0007 |
| 318 |
GENERALISED OEDEMA |
9 |
0.0007 |
| 319 |
RESPIRATORY DISTRESS |
20 |
0.0007 |
| 320 |
RED CELL DISTRIBUTION WIDTH INCREASED |
3 |
0.0007 |
| 321 |
ASCITES |
21 |
0.0007 |
| 322 |
ANAL HAEMORRHAGE |
2 |
0.0007 |
| 323 |
ACUTE PULMONARY OEDEMA |
4 |
0.0007 |
| 324 |
HEPATOMEGALY |
7 |
0.0007 |
| 325 |
REBOUND EFFECT |
8 |
0.0007 |
| 326 |
FEBRILE BONE MARROW APLASIA |
3 |
0.0007 |
| 327 |
ESCHERICHIA URINARY TRACT INFECTION |
3 |
0.0007 |
| 328 |
INCORRECT DRUG ADMINISTRATION RATE |
3 |
0.0007 |
| 329 |
GRANULOCYTOPENIA |
4 |
0.0007 |
| 330 |
PRODUCT DISPENSING ISSUE |
3 |
0.0007 |
| 331 |
LEFT VENTRICULAR HYPERTROPHY |
3 |
0.0007 |
| 332 |
BLOOD POTASSIUM DECREASED |
21 |
0.0007 |
| 333 |
PRODUCT USE COMPLAINT |
11 |
0.0007 |
| 334 |
BACTERIAL INFECTION |
13 |
0.0007 |
| 335 |
OCULAR ICTERUS |
3 |
0.0007 |
| 336 |
FEEDING DISORDER |
14 |
0.0007 |
| 337 |
HYPERVENTILATION |
4 |
0.0007 |
| 338 |
DYSPHEMIA |
3 |
0.0007 |
| 339 |
PARONYCHIA |
3 |
0.0007 |
| 340 |
ACUTE RESPIRATORY FAILURE |
13 |
0.0007 |
| 341 |
ARTHROPOD BITE |
5 |
0.0007 |
| 342 |
PROTHROMBIN TIME PROLONGED |
4 |
0.0007 |
| 343 |
RESPIRATORY DISORDER |
20 |
0.0007 |
| 344 |
MENINGITIS ASEPTIC |
3 |
0.0007 |
| 345 |
ANAL INCONTINENCE |
6 |
0.0007 |
| 346 |
LETHARGY |
38 |
0.0007 |
| 347 |
ACUTE HEPATIC FAILURE |
9 |
0.0007 |
| 348 |
HAEMOGLOBIN INCREASED |
3 |
0.0007 |
| 349 |
TROPONIN INCREASED |
5 |
0.0007 |
| 350 |
SOMNOLENCE |
132 |
0.0007 |
| 351 |
RENAL FAILURE CHRONIC |
5 |
0.0006 |
| 352 |
DIFFUSE LARGE B-CELL LYMPHOMA |
5 |
0.0006 |
| 353 |
NEPHROGENIC ANAEMIA |
3 |
0.0006 |
| 354 |
CONVULSION |
37 |
0.0006 |
| 355 |
PHARYNGITIS STREPTOCOCCAL |
7 |
0.0006 |
| 356 |
LOW DENSITY LIPOPROTEIN INCREASED |
5 |
0.0006 |
| 357 |
PANCREATITIS |
34 |
0.0006 |
| 358 |
APPENDICITIS |
6 |
0.0006 |
| 359 |
AGGRESSION |
32 |
0.0006 |
| 360 |
SKIN TIGHTNESS |
3 |
0.0006 |
| 361 |
AFFECTIVE DISORDER |
5 |
0.0006 |
| 362 |
SLEEP APNOEA SYNDROME |
12 |
0.0006 |
| 363 |
HEPATIC CYTOLYSIS |
8 |
0.0006 |
| 364 |
CARDIOGENIC SHOCK |
9 |
0.0006 |
| 365 |
SUPRAVENTRICULAR TACHYCARDIA |
6 |
0.0006 |
| 366 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
18 |
0.0006 |
| 367 |
SKIN INFECTION |
7 |
0.0006 |
| 368 |
HUMERUS FRACTURE |
3 |
0.0006 |
| 369 |
ENTEROCOCCAL INFECTION |
3 |
0.0006 |
| 370 |
INFUSION SITE PAIN |
8 |
0.0006 |
| 371 |
FRUSTRATION TOLERANCE DECREASED |
5 |
0.0006 |
| 372 |
HEPATIC FUNCTION ABNORMAL |
23 |
0.0006 |
| 373 |
APPETITE DISORDER |
4 |
0.0006 |
| 374 |
FEBRILE NEUTROPENIA |
40 |
0.0006 |
| 375 |
FLUID INTAKE REDUCED |
3 |
0.0006 |
| 376 |
SEPTIC SHOCK |
26 |
0.0006 |
| 377 |
DYSKINESIA |
24 |
0.0006 |
| 378 |
INSURANCE ISSUE |
9 |
0.0006 |
| 379 |
HOSPITALISATION |
90 |
0.0006 |
| 380 |
HEPATIC CIRRHOSIS |
11 |
0.0006 |
| 381 |
INITIAL INSOMNIA |
6 |
0.0006 |
| 382 |
EYE MOVEMENT DISORDER |
4 |
0.0006 |
| 383 |
BLOOD SODIUM DECREASED |
11 |
0.0006 |
| 384 |
CACHEXIA |
3 |
0.0006 |
| 385 |
TONSILLITIS |
3 |
0.0006 |
| 386 |
MALABSORPTION |
3 |
0.0006 |
| 387 |
PNEUMONIA |
185 |
0.0006 |
| 388 |
BLOOD TEST ABNORMAL |
8 |
0.0006 |
| 389 |
IRRITABILITY |
34 |
0.0006 |
| 390 |
INFLUENZA |
63 |
0.0006 |
| 391 |
COMPRESSION FRACTURE |
3 |
0.0006 |
| 392 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
4 |
0.0006 |
| 393 |
BRUXISM |
3 |
0.0006 |
| 394 |
OROPHARYNGEAL DISCOMFORT |
5 |
0.0006 |
| 395 |
FAECES SOFT |
4 |
0.0005 |
| 396 |
DRUG LEVEL INCREASED |
9 |
0.0005 |
| 397 |
PSYCHOMOTOR HYPERACTIVITY |
9 |
0.0005 |
| 398 |
GASTRIC ULCER HAEMORRHAGE |
3 |
0.0005 |
| 399 |
VENTRICULAR FIBRILLATION |
6 |
0.0005 |
| 400 |
PERSONALITY CHANGE |
5 |
0.0005 |
| 401 |
SEDATION |
14 |
0.0005 |
| 402 |
PERITONITIS |
11 |
0.0005 |
| 403 |
AGITATION |
39 |
0.0005 |
| 404 |
DECREASED APPETITE |
123 |
0.0005 |
| 405 |
HYPOCALCAEMIA |
10 |
0.0005 |
| 406 |
OSTEOPENIA |
8 |
0.0005 |
| 407 |
DERMATITIS CONTACT |
6 |
0.0005 |
| 408 |
CARDIAC VALVE DISEASE |
3 |
0.0005 |
| 409 |
HYPERTHERMIA |
4 |
0.0005 |
| 410 |
BOWEL MOVEMENT IRREGULARITY |
4 |
0.0005 |
| 411 |
FEMUR FRACTURE |
16 |
0.0005 |
| 412 |
RALES |
3 |
0.0005 |
| 413 |
EATING DISORDER |
11 |
0.0005 |
| 414 |
BRONCHOPULMONARY ASPERGILLOSIS |
4 |
0.0005 |
| 415 |
HYPOVOLAEMIA |
3 |
0.0005 |
| 416 |
SPLENOMEGALY |
6 |
0.0005 |
| 417 |
SEPSIS |
57 |
0.0005 |
| 418 |
POOR QUALITY SLEEP |
11 |
0.0005 |
| 419 |
MULTIPLE ALLERGIES |
4 |
0.0005 |
| 420 |
THERAPY CHANGE |
5 |
0.0005 |
| 421 |
UNDERDOSE |
37 |
0.0005 |
| 422 |
PYREXIA |
175 |
0.0005 |
| 423 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
8 |
0.0005 |
| 424 |
MENTAL STATUS CHANGES |
14 |
0.0005 |
| 425 |
PANCYTOPENIA |
28 |
0.0005 |
| 426 |
ELECTROCARDIOGRAM QT PROLONGED |
18 |
0.0005 |
| 427 |
TYPE 1 DIABETES MELLITUS |
3 |
0.0005 |
| 428 |
SENSORY LOSS |
4 |
0.0005 |
| 429 |
HYPOTHERMIA |
5 |
0.0005 |
| 430 |
HEPATOCELLULAR INJURY |
7 |
0.0005 |
| 431 |
VOMITING |
232 |
0.0005 |
| 432 |
DERMATITIS ACNEIFORM |
3 |
0.0005 |
| 433 |
POLYURIA |
4 |
0.0005 |
| 434 |
ABNORMAL FAECES |
4 |
0.0005 |
| 435 |
ANAPHYLACTOID REACTION |
2 |
0.0005 |
| 436 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
3 |
0.0005 |
| 437 |
CHOLANGITIS |
3 |
0.0005 |
| 438 |
HYPERTHYROIDISM |
7 |
0.0005 |
| 439 |
JAUNDICE |
13 |
0.0005 |
| 440 |
VENTRICULAR EXTRASYSTOLES |
5 |
0.0005 |
| 441 |
PRE-EXISTING CONDITION IMPROVED |
3 |
0.0005 |
| 442 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
19 |
0.0005 |
| 443 |
DEHYDRATION |
64 |
0.0005 |
| 444 |
NEPHROLITHIASIS |
22 |
0.0005 |
| 445 |
SWELLING OF EYELID |
3 |
0.0005 |
| 446 |
PERICARDIAL EFFUSION |
11 |
0.0005 |
| 447 |
CARDIOMYOPATHY |
7 |
0.0005 |
| 448 |
PROTEINURIA |
9 |
0.0005 |
| 449 |
INCONTINENCE |
5 |
0.0005 |
| 450 |
FULL BLOOD COUNT ABNORMAL |
5 |
0.0005 |
| 451 |
ALANINE AMINOTRANSFERASE INCREASED |
29 |
0.0005 |
| 452 |
HAEMATURIA |
16 |
0.0005 |
| 453 |
PROCTALGIA |
3 |
0.0005 |
| 454 |
ABNORMAL SENSATION IN EYE |
2 |
0.0005 |
| 455 |
BLOOD MAGNESIUM DECREASED |
4 |
0.0005 |
| 456 |
PRODUCT DOSE OMISSION ISSUE |
136 |
0.0005 |
| 457 |
CARDIAC ARREST |
38 |
0.0005 |
| 458 |
REFUSAL OF TREATMENT BY PATIENT |
3 |
0.0005 |
| 459 |
POLYP |
3 |
0.0005 |
| 460 |
INTERNATIONAL NORMALISED RATIO INCREASED |
13 |
0.0005 |
| 461 |
PURPURA |
4 |
0.0005 |
| 462 |
COVID-19 |
79 |
0.0004 |
| 463 |
THERAPY PARTIAL RESPONDER |
7 |
0.0004 |
| 464 |
NERVOUS SYSTEM DISORDER |
14 |
0.0004 |
| 465 |
CARDIOTOXICITY |
4 |
0.0004 |
| 466 |
LEFT VENTRICULAR DYSFUNCTION |
3 |
0.0004 |
| 467 |
HAEMOLYTIC ANAEMIA |
4 |
0.0004 |
| 468 |
ULCER HAEMORRHAGE |
3 |
0.0004 |
| 469 |
LEUKOCYTOSIS |
8 |
0.0004 |
| 470 |
LIP DRY |
4 |
0.0004 |
| 471 |
BLOOD TESTOSTERONE DECREASED |
3 |
0.0004 |
| 472 |
RESTLESSNESS |
16 |
0.0004 |
| 473 |
ENCEPHALITIS |
3 |
0.0004 |
| 474 |
UROSEPSIS |
4 |
0.0004 |
| 475 |
HYPERTRANSAMINASAEMIA |
3 |
0.0004 |
| 476 |
CONJUNCTIVITIS |
8 |
0.0004 |
| 477 |
ELECTROLYTE IMBALANCE |
5 |
0.0004 |
| 478 |
EXTRASYSTOLES |
3 |
0.0004 |
| 479 |
HEPATIC STEATOSIS |
8 |
0.0004 |
| 480 |
MOUTH ULCERATION |
9 |
0.0004 |
| 481 |
DISSEMINATED INTRAVASCULAR COAGULATION |
6 |
0.0004 |
| 482 |
PHOTOPHOBIA |
8 |
0.0004 |
| 483 |
SEASONAL ALLERGY |
6 |
0.0004 |
| 484 |
DIVERTICULUM |
3 |
0.0004 |
| 485 |
FEAR OF INJECTION |
3 |
0.0004 |
| 486 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
4 |
0.0004 |
| 487 |
INCREASED APPETITE |
8 |
0.0004 |
| 488 |
CELLULITIS |
21 |
0.0004 |
| 489 |
ASPARTATE AMINOTRANSFERASE INCREASED |
22 |
0.0004 |
| 490 |
HYPOKALAEMIA |
19 |
0.0004 |
| 491 |
NEURALGIA |
10 |
0.0004 |
| 492 |
UPPER RESPIRATORY TRACT INFECTION |
19 |
0.0004 |
| 493 |
THROMBOTIC MICROANGIOPATHY |
4 |
0.0004 |
| 494 |
ILLNESS |
42 |
0.0004 |
| 495 |
LIVER INJURY |
10 |
0.0004 |
| 496 |
HYPOTHYROIDISM |
13 |
0.0004 |
| 497 |
HYPERCALCAEMIA |
5 |
0.0004 |
| 498 |
LACTIC ACIDOSIS |
13 |
0.0004 |
| 499 |
SALIVARY HYPERSECRETION |
4 |
0.0004 |
| 500 |
RESPIRATORY ARREST |
11 |
0.0004 |
| 501 |
SLEEP DISORDER |
28 |
0.0004 |
| 502 |
BLOOD TRIGLYCERIDES INCREASED |
7 |
0.0004 |
| 503 |
BRAIN OEDEMA |
5 |
0.0004 |
| 504 |
PLATELET COUNT DECREASED |
42 |
0.0004 |
| 505 |
BONE MARROW FAILURE |
8 |
0.0004 |
| 506 |
URINARY RETENTION |
13 |
0.0004 |
| 507 |
FOOD ALLERGY |
3 |
0.0004 |
| 508 |
URINARY TRACT INFECTION |
66 |
0.0004 |
| 509 |
EJECTION FRACTION DECREASED |
6 |
0.0004 |
| 510 |
PELVIC FRACTURE |
3 |
0.0004 |
| 511 |
PULMONARY HYPERTENSION |
8 |
0.0004 |
| 512 |
GASTROINTESTINAL INFLAMMATION |
3 |
0.0004 |
| 513 |
CARDIO-RESPIRATORY ARREST |
16 |
0.0004 |
| 514 |
HEPATIC ENZYME INCREASED |
26 |
0.0004 |
| 515 |
HEAD INJURY |
12 |
0.0004 |
| 516 |
FURUNCLE |
3 |
0.0004 |
| 517 |
CONSTIPATION |
82 |
0.0004 |
| 518 |
SURGERY |
22 |
0.0004 |
| 519 |
ANAL FISTULA |
2 |
0.0004 |
| 520 |
TRANSPLANT REJECTION |
3 |
0.0004 |
| 521 |
OBSESSIVE-COMPULSIVE DISORDER |
3 |
0.0004 |
| 522 |
ANAL ABSCESS |
2 |
0.0004 |
| 523 |
FIBROMYALGIA |
9 |
0.0004 |
| 524 |
FREQUENT BOWEL MOVEMENTS |
10 |
0.0004 |
| 525 |
SINUS CONGESTION |
5 |
0.0004 |
| 526 |
SHOCK HAEMORRHAGIC |
3 |
0.0004 |
| 527 |
SKIN LACERATION |
4 |
0.0004 |
| 528 |
PRODUCT DISPENSING ERROR |
8 |
0.0004 |
| 529 |
MOOD ALTERED |
10 |
0.0004 |
| 530 |
UPPER-AIRWAY COUGH SYNDROME |
3 |
0.0004 |
| 531 |
TOOTH FRACTURE |
4 |
0.0004 |
| 532 |
THERAPEUTIC RESPONSE DECREASED |
22 |
0.0004 |
| 533 |
DENTAL CARIES |
4 |
0.0004 |
| 534 |
CARDIAC FAILURE |
29 |
0.0004 |
| 535 |
SINUSITIS |
37 |
0.0004 |
| 536 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
8 |
0.0004 |
| 537 |
LIVER DISORDER |
16 |
0.0004 |
| 538 |
TRANSAMINASES INCREASED |
8 |
0.0004 |
| 539 |
INFECTION |
52 |
0.0004 |
| 540 |
OCULAR DISCOMFORT |
4 |
0.0004 |
| 541 |
OXYGEN SATURATION DECREASED |
20 |
0.0004 |
| 542 |
BLOOD CALCIUM DECREASED |
4 |
0.0004 |
| 543 |
CANDIDA INFECTION |
6 |
0.0004 |
| 544 |
DEVICE OCCLUSION |
5 |
0.0004 |
| 545 |
ANGER |
12 |
0.0004 |
| 546 |
EYE INFECTION |
4 |
0.0004 |
| 547 |
HEMIPARESIS |
6 |
0.0004 |
| 548 |
OFF LABEL USE |
310 |
0.0004 |
| 549 |
HAEMATOCRIT DECREASED |
7 |
0.0004 |
| 550 |
FACIAL PARALYSIS |
3 |
0.0004 |
| 551 |
VITAMIN D DECREASED |
3 |
0.0004 |
| 552 |
INTENTIONAL DOSE OMISSION |
10 |
0.0004 |
| 553 |
DRUG-INDUCED LIVER INJURY |
11 |
0.0004 |
| 554 |
PSEUDOMONAS INFECTION |
3 |
0.0003 |
| 555 |
RED BLOOD CELL COUNT DECREASED |
10 |
0.0003 |
| 556 |
CARDIAC OPERATION |
3 |
0.0003 |
| 557 |
TACHYCARDIA |
31 |
0.0003 |
| 558 |
ANURIA |
3 |
0.0003 |
| 559 |
EYE IRRITATION |
20 |
0.0003 |
| 560 |
MULTI-ORGAN FAILURE |
6 |
0.0003 |
| 561 |
PRODUCT ADMINISTRATION ERROR |
7 |
0.0003 |
| 562 |
PYELONEPHRITIS |
3 |
0.0003 |
| 563 |
PULMONARY ARTERIAL HYPERTENSION |
5 |
0.0003 |
| 564 |
ABDOMINAL DISTENSION |
36 |
0.0003 |
| 565 |
COMPLICATION ASSOCIATED WITH DEVICE |
5 |
0.0003 |
| 566 |
NEUTROPHIL COUNT DECREASED |
14 |
0.0003 |
| 567 |
VASCULITIS |
4 |
0.0003 |
| 568 |
WHITE BLOOD CELL COUNT DECREASED |
37 |
0.0003 |
| 569 |
TUMOUR LYSIS SYNDROME |
3 |
0.0003 |
| 570 |
PRODUCT COMMUNICATION ISSUE |
3 |
0.0003 |
| 571 |
LABORATORY TEST ABNORMAL |
10 |
0.0003 |
| 572 |
WHITE BLOOD CELL COUNT INCREASED |
13 |
0.0003 |
| 573 |
URINARY INCONTINENCE |
10 |
0.0003 |
| 574 |
BLOOD CREATININE INCREASED |
22 |
0.0003 |
| 575 |
EYE PAIN |
19 |
0.0003 |
| 576 |
NASOPHARYNGITIS |
62 |
0.0003 |
| 577 |
IMMUNODEFICIENCY |
5 |
0.0003 |
| 578 |
GASTROINTESTINAL DISORDER |
30 |
0.0003 |
| 579 |
GASTROINTESTINAL INFECTION |
3 |
0.0003 |
| 580 |
APHASIA |
10 |
0.0003 |
| 581 |
PNEUMONITIS |
9 |
0.0003 |
| 582 |
NOCTURIA |
4 |
0.0003 |
| 583 |
OEDEMA PERIPHERAL |
40 |
0.0003 |
| 584 |
DIARRHOEA |
211 |
0.0003 |
| 585 |
PRODUCT USE IN UNAPPROVED INDICATION |
81 |
0.0003 |
| 586 |
WEIGHT DECREASED |
91 |
0.0003 |
| 587 |
MUSCLE SPASTICITY |
4 |
0.0003 |
| 588 |
CARDIOMEGALY |
4 |
0.0003 |
| 589 |
ANKLE FRACTURE |
5 |
0.0003 |
| 590 |
GASTROOESOPHAGEAL REFLUX DISEASE |
26 |
0.0003 |
| 591 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
8 |
0.0003 |
| 592 |
THROMBOCYTOPENIA |
36 |
0.0003 |
| 593 |
LUNG INFECTION |
5 |
0.0003 |
| 594 |
ERYTHEMA MULTIFORME |
3 |
0.0003 |
| 595 |
ABORTION INDUCED |
3 |
0.0003 |
| 596 |
INTESTINAL OBSTRUCTION |
12 |
0.0003 |
| 597 |
MUSCULAR WEAKNESS |
36 |
0.0003 |
| 598 |
COLITIS |
12 |
0.0003 |
| 599 |
SPUTUM DISCOLOURED |
3 |
0.0003 |
| 600 |
MUSCLE ATROPHY |
4 |
0.0003 |
| 601 |
NEUROPATHY PERIPHERAL |
30 |
0.0003 |
| 602 |
COMA |
15 |
0.0003 |
| 603 |
PULMONARY OEDEMA |
14 |
0.0003 |
| 604 |
HAEMOGLOBIN DECREASED |
32 |
0.0003 |
| 605 |
SENSORY DISTURBANCE |
5 |
0.0003 |
| 606 |
MOVEMENT DISORDER |
10 |
0.0003 |
| 607 |
HYPERCHOLESTEROLAEMIA |
3 |
0.0003 |
| 608 |
CHROMATURIA |
7 |
0.0003 |
| 609 |
UNRESPONSIVE TO STIMULI |
8 |
0.0003 |
| 610 |
AUTOIMMUNE DISORDER |
3 |
0.0003 |
| 611 |
ANGINA UNSTABLE |
2 |
0.0003 |
| 612 |
PARKINSONISM |
3 |
0.0003 |
| 613 |
HAEMORRHOIDS |
6 |
0.0003 |
| 614 |
TREMOR |
51 |
0.0003 |
| 615 |
PLATELET COUNT INCREASED |
4 |
0.0003 |
| 616 |
NASAL CONGESTION |
18 |
0.0003 |
| 617 |
BODY TEMPERATURE DECREASED |
3 |
0.0003 |
| 618 |
LIGAMENT SPRAIN |
3 |
0.0003 |
| 619 |
CRYING |
11 |
0.0003 |
| 620 |
RECTAL HAEMORRHAGE |
13 |
0.0003 |
| 621 |
BLOOD PRESSURE DECREASED |
20 |
0.0003 |
| 622 |
BRAIN INJURY |
3 |
0.0003 |
| 623 |
WEIGHT INCREASED |
67 |
0.0003 |
| 624 |
EMPHYSEMA |
3 |
0.0003 |
| 625 |
FACE OEDEMA |
5 |
0.0003 |
| 626 |
DRUG LEVEL DECREASED |
3 |
0.0003 |
| 627 |
MOTOR DYSFUNCTION |
3 |
0.0003 |
| 628 |
DISEASE RECURRENCE |
14 |
0.0003 |
| 629 |
BODY TEMPERATURE INCREASED |
6 |
0.0003 |
| 630 |
IMPAIRED GASTRIC EMPTYING |
4 |
0.0003 |
| 631 |
ABNORMAL LOSS OF WEIGHT |
2 |
0.0003 |
| 632 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
3 |
0.0003 |
| 633 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
16 |
0.0003 |
| 634 |
PERIPHERAL COLDNESS |
4 |
0.0003 |
| 635 |
MUSCULOSKELETAL DISCOMFORT |
5 |
0.0003 |
| 636 |
TENDERNESS |
3 |
0.0003 |
| 637 |
PETECHIAE |
3 |
0.0003 |
| 638 |
WEIGHT FLUCTUATION |
3 |
0.0003 |
| 639 |
PRODUCT ODOUR ABNORMAL |
3 |
0.0003 |
| 640 |
TRANSFUSION |
3 |
0.0003 |
| 641 |
HEART RATE DECREASED |
10 |
0.0003 |
| 642 |
HALLUCINATION, VISUAL |
6 |
0.0003 |
| 643 |
HYPONATRAEMIA |
16 |
0.0003 |
| 644 |
SUDDEN DEATH |
3 |
0.0003 |
| 645 |
RENAL PAIN |
3 |
0.0003 |
| 646 |
DIABETES MELLITUS INADEQUATE CONTROL |
5 |
0.0003 |
| 647 |
FLATULENCE |
16 |
0.0003 |
| 648 |
THIRST |
5 |
0.0003 |
| 649 |
LIVER FUNCTION TEST INCREASED |
6 |
0.0003 |
| 650 |
ANGINA PECTORIS |
8 |
0.0003 |
| 651 |
COUGH |
78 |
0.0003 |
| 652 |
DRUG INTERACTION |
44 |
0.0003 |
| 653 |
OEDEMA |
15 |
0.0003 |
| 654 |
OSTEOMYELITIS |
5 |
0.0003 |
| 655 |
ABDOMINAL PAIN |
64 |
0.0003 |
| 656 |
RESTLESS LEGS SYNDROME |
5 |
0.0003 |
| 657 |
FLUID OVERLOAD |
4 |
0.0003 |
| 658 |
END STAGE RENAL DISEASE |
5 |
0.0003 |
| 659 |
CONDITION AGGRAVATED |
83 |
0.0003 |
| 660 |
APPLICATION SITE PAIN |
6 |
0.0003 |
| 661 |
MEDICATION ERROR |
15 |
0.0003 |
| 662 |
HEPATOTOXICITY |
6 |
0.0003 |
| 663 |
AGRANULOCYTOSIS |
5 |
0.0003 |
| 664 |
ANAEMIA |
51 |
0.0003 |
| 665 |
EPISTAXIS |
20 |
0.0003 |
| 666 |
SPEECH DISORDER |
14 |
0.0003 |
| 667 |
GASTRITIS |
7 |
0.0003 |
| 668 |
FOOT FRACTURE |
5 |
0.0003 |
| 669 |
BLOOD URINE PRESENT |
5 |
0.0003 |
| 670 |
LOWER LIMB FRACTURE |
5 |
0.0003 |
| 671 |
BLOOD CHOLESTEROL INCREASED |
12 |
0.0003 |
| 672 |
PALLOR |
7 |
0.0003 |
| 673 |
COGNITIVE DISORDER |
12 |
0.0003 |
| 674 |
BRONCHITIS |
19 |
0.0003 |
| 675 |
HYPERKALAEMIA |
9 |
0.0003 |
| 676 |
CHOKING |
5 |
0.0003 |
| 677 |
INSOMNIA |
68 |
0.0003 |
| 678 |
OVERDOSE |
55 |
0.0003 |
| 679 |
CYANOSIS |
4 |
0.0003 |
| 680 |
HYPOTENSION |
51 |
0.0003 |
| 681 |
COVID-19 PNEUMONIA |
3 |
0.0003 |
| 682 |
BLOOD IRON DECREASED |
3 |
0.0003 |
| 683 |
ATAXIA |
3 |
0.0003 |
| 684 |
DISORIENTATION |
10 |
0.0003 |
| 685 |
PNEUMOTHORAX |
4 |
0.0003 |
| 686 |
CHOLECYSTITIS |
3 |
0.0003 |
| 687 |
PRODUCTIVE COUGH |
12 |
0.0003 |
| 688 |
ACCIDENT |
3 |
0.0003 |
| 689 |
SCIATICA |
4 |
0.0003 |
| 690 |
POLYNEUROPATHY |
3 |
0.0003 |
| 691 |
NECK PAIN |
14 |
0.0003 |
| 692 |
WRIST FRACTURE |
3 |
0.0003 |
| 693 |
RENAL FAILURE |
33 |
0.0002 |
| 694 |
C-REACTIVE PROTEIN INCREASED |
9 |
0.0002 |
| 695 |
TASTE DISORDER |
5 |
0.0002 |
| 696 |
BLOOD POTASSIUM INCREASED |
4 |
0.0002 |
| 697 |
STAPHYLOCOCCAL INFECTION |
8 |
0.0002 |
| 698 |
VENTRICULAR TACHYCARDIA |
4 |
0.0002 |
| 699 |
PHARYNGITIS |
3 |
0.0002 |
| 700 |
ACUTE CORONARY SYNDROME |
2 |
0.0002 |
| 701 |
FATIGUE |
188 |
0.0002 |
| 702 |
TREATMENT FAILURE |
20 |
0.0002 |
| 703 |
CYTOMEGALOVIRUS INFECTION |
4 |
0.0002 |
| 704 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0002 |
| 705 |
HAEMATOCHEZIA |
13 |
0.0002 |
| 706 |
FALL |
78 |
0.0002 |
| 707 |
IMPAIRED WORK ABILITY |
5 |
0.0002 |
| 708 |
MYDRIASIS |
3 |
0.0002 |
| 709 |
ANOREXIA |
3 |
0.0002 |
| 710 |
ANAPHYLACTIC SHOCK |
6 |
0.0002 |
| 711 |
ABDOMINAL DISCOMFORT |
39 |
0.0002 |
| 712 |
DELIRIUM |
8 |
0.0002 |
| 713 |
NODULE |
3 |
0.0002 |
| 714 |
MENTAL DISORDER |
10 |
0.0002 |
| 715 |
CLOSTRIDIUM DIFFICILE INFECTION |
5 |
0.0002 |
| 716 |
MELAENA |
5 |
0.0002 |
| 717 |
RENAL IMPAIRMENT |
19 |
0.0002 |
| 718 |
GAIT DISTURBANCE |
43 |
0.0002 |
| 719 |
PANCREATITIS ACUTE |
5 |
0.0002 |
| 720 |
HEART RATE INCREASED |
22 |
0.0002 |
| 721 |
DEVICE BREAKAGE |
9 |
0.0002 |
| 722 |
OSTEOPOROSIS |
9 |
0.0002 |
| 723 |
MUSCLE TWITCHING |
5 |
0.0002 |
| 724 |
RHINORRHOEA |
14 |
0.0002 |
| 725 |
DIVERTICULITIS |
6 |
0.0002 |
| 726 |
PRODUCT DOSE OMISSION |
14 |
0.0002 |
| 727 |
STOMATITIS |
13 |
0.0002 |
| 728 |
MIDDLE INSOMNIA |
4 |
0.0002 |
| 729 |
ABDOMINAL PAIN UPPER |
44 |
0.0002 |
| 730 |
PLEURAL EFFUSION |
13 |
0.0002 |
| 731 |
DISCOMFORT |
13 |
0.0002 |
| 732 |
PRODUCT USE ISSUE |
40 |
0.0002 |
| 733 |
LYMPHOPENIA |
3 |
0.0002 |
| 734 |
FRACTURE |
4 |
0.0002 |
| 735 |
ARRHYTHMIA |
10 |
0.0002 |
| 736 |
LOSS OF CONSCIOUSNESS |
27 |
0.0002 |
| 737 |
FUNGAL INFECTION |
7 |
0.0002 |
| 738 |
FEELING JITTERY |
4 |
0.0002 |
| 739 |
SYNCOPE |
21 |
0.0002 |
| 740 |
PARALYSIS |
3 |
0.0002 |
| 741 |
GAIT INABILITY |
7 |
0.0002 |
| 742 |
BALANCE DISORDER |
18 |
0.0002 |
| 743 |
DIABETIC KETOACIDOSIS |
5 |
0.0002 |
| 744 |
CONTUSION |
20 |
0.0002 |
| 745 |
GLAUCOMA |
4 |
0.0002 |
| 746 |
TRANSIENT ISCHAEMIC ATTACK |
7 |
0.0002 |
| 747 |
LOCALISED INFECTION |
5 |
0.0002 |
| 748 |
HYPOGLYCAEMIA |
10 |
0.0002 |
| 749 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
37 |
0.0002 |
| 750 |
BLOOD PRESSURE SYSTOLIC INCREASED |
4 |
0.0002 |
| 751 |
ORAL HERPES |
4 |
0.0002 |
| 752 |
KIDNEY INFECTION |
4 |
0.0002 |
| 753 |
ACUTE MYOCARDIAL INFARCTION |
6 |
0.0002 |
| 754 |
BLOOD PRESSURE INCREASED |
31 |
0.0002 |
| 755 |
DRUG EFFECT LESS THAN EXPECTED |
3 |
0.0002 |
| 756 |
DISABILITY |
4 |
0.0002 |
| 757 |
DYSPHAGIA |
19 |
0.0002 |
| 758 |
DEEP VEIN THROMBOSIS |
13 |
0.0002 |
| 759 |
SPINAL FRACTURE |
4 |
0.0002 |
| 760 |
CYTOKINE RELEASE SYNDROME |
4 |
0.0002 |
| 761 |
LACRIMATION INCREASED |
6 |
0.0002 |
| 762 |
ECONOMIC PROBLEM |
3 |
0.0002 |
| 763 |
TOXICITY TO VARIOUS AGENTS |
33 |
0.0002 |
| 764 |
HEPATITIS |
5 |
0.0002 |
| 765 |
PRODUCT PREPARATION ERROR |
4 |
0.0002 |
| 766 |
THYROID DISORDER |
3 |
0.0002 |
| 767 |
EMOTIONAL DISORDER |
6 |
0.0002 |
| 768 |
RIB FRACTURE |
4 |
0.0002 |
| 769 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
5 |
0.0002 |
| 770 |
INTENTIONAL PRODUCT MISUSE |
17 |
0.0002 |
| 771 |
LIMB DISCOMFORT |
6 |
0.0002 |
| 772 |
MUSCULOSKELETAL CHEST PAIN |
3 |
0.0002 |
| 773 |
DELUSION |
3 |
0.0002 |
| 774 |
BRAIN FOG |
3 |
0.0002 |
| 775 |
NERVOUSNESS |
10 |
0.0002 |
| 776 |
PRODUCT SUBSTITUTION ISSUE |
11 |
0.0002 |
| 777 |
ADVERSE DRUG REACTION |
17 |
0.0002 |
| 778 |
DYSPNOEA |
107 |
0.0002 |
| 779 |
MOOD SWINGS |
6 |
0.0002 |
| 780 |
CARDIAC FAILURE CONGESTIVE |
15 |
0.0002 |
| 781 |
DRUG INTOLERANCE |
18 |
0.0002 |
| 782 |
DISTURBANCE IN ATTENTION |
10 |
0.0002 |
| 783 |
BACK DISORDER |
3 |
0.0002 |
| 784 |
ADVERSE EVENT |
17 |
0.0002 |
| 785 |
LIMB INJURY |
5 |
0.0002 |
| 786 |
INTERVERTEBRAL DISC PROTRUSION |
4 |
0.0002 |
| 787 |
TREATMENT NONCOMPLIANCE |
10 |
0.0002 |
| 788 |
GENERAL PHYSICAL HEALTH DETERIORATION |
21 |
0.0002 |
| 789 |
ABNORMAL DREAMS |
5 |
0.0002 |
| 790 |
MUSCLE SPASMS |
33 |
0.0002 |
| 791 |
GASTROINTESTINAL HAEMORRHAGE |
15 |
0.0002 |
| 792 |
RASH PAPULAR |
4 |
0.0002 |
| 793 |
THERAPEUTIC RESPONSE UNEXPECTED |
8 |
0.0002 |
| 794 |
MIGRAINE |
17 |
0.0002 |
| 795 |
PARAESTHESIA |
28 |
0.0002 |
| 796 |
DISEASE PROGRESSION |
21 |
0.0002 |
| 797 |
HEART RATE IRREGULAR |
4 |
0.0002 |
| 798 |
NEUTROPENIA |
24 |
0.0002 |
| 799 |
PRODUCT AVAILABILITY ISSUE |
4 |
0.0002 |
| 800 |
ASTHENIA |
66 |
0.0002 |
| 801 |
INFLAMMATION |
9 |
0.0002 |
| 802 |
THROMBOSIS |
14 |
0.0002 |
| 803 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
9 |
0.0002 |
| 804 |
MUSCULOSKELETAL STIFFNESS |
15 |
0.0002 |
| 805 |
NEUROTOXICITY |
3 |
0.0002 |
| 806 |
CHRONIC KIDNEY DISEASE |
13 |
0.0002 |
| 807 |
NAUSEA |
135 |
0.0002 |
| 808 |
PSYCHOTIC DISORDER |
5 |
0.0002 |
| 809 |
DRUG ERUPTION |
3 |
0.0002 |
| 810 |
PERIPHERAL SWELLING |
26 |
0.0002 |
| 811 |
OCULAR HYPERAEMIA |
8 |
0.0002 |
| 812 |
PULMONARY EMBOLISM |
16 |
0.0002 |
| 813 |
POLLAKIURIA |
7 |
0.0002 |
| 814 |
GOUT |
3 |
0.0002 |
| 815 |
BLOOD GLUCOSE DECREASED |
8 |
0.0002 |
| 816 |
CORONARY ARTERY DISEASE |
5 |
0.0002 |
| 817 |
ILL-DEFINED DISORDER |
10 |
0.0002 |
| 818 |
CEREBRAL INFARCTION |
4 |
0.0002 |
| 819 |
LUNG DISORDER |
8 |
0.0002 |
| 820 |
DYSURIA |
6 |
0.0002 |
| 821 |
RASH |
71 |
0.0002 |
| 822 |
THINKING ABNORMAL |
3 |
0.0002 |
| 823 |
AGEUSIA |
4 |
0.0002 |
| 824 |
DRY EYE |
8 |
0.0002 |
| 825 |
LEUKOPENIA |
8 |
0.0002 |
| 826 |
INFLUENZA LIKE ILLNESS |
13 |
0.0002 |
| 827 |
HAEMATEMESIS |
4 |
0.0002 |
| 828 |
CARDIOVASCULAR DISORDER |
4 |
0.0002 |
| 829 |
CHEST DISCOMFORT |
16 |
0.0002 |
| 830 |
POST PROCEDURAL COMPLICATION |
3 |
0.0002 |
| 831 |
HYPERTENSION |
33 |
0.0002 |
| 832 |
HIP FRACTURE |
5 |
0.0002 |
| 833 |
ERUCTATION |
3 |
0.0002 |
| 834 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
11 |
0.0002 |
| 835 |
ANXIETY |
44 |
0.0002 |
| 836 |
MEMORY IMPAIRMENT |
21 |
0.0002 |
| 837 |
CHOLELITHIASIS |
5 |
0.0002 |
| 838 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
3 |
0.0002 |
| 839 |
SINUS DISORDER |
3 |
0.0002 |
| 840 |
OROPHARYNGEAL PAIN |
14 |
0.0002 |
| 841 |
BLOOD PRESSURE ABNORMAL |
3 |
0.0002 |
| 842 |
UPPER LIMB FRACTURE |
3 |
0.0002 |
| 843 |
LIP SWELLING |
5 |
0.0001 |
| 844 |
DRUG INEFFECTIVE |
196 |
0.0001 |
| 845 |
BLOOD GLUCOSE INCREASED |
28 |
0.0001 |
| 846 |
RASH PRURITIC |
8 |
0.0001 |
| 847 |
MYALGIA |
25 |
0.0001 |
| 848 |
FEELING HOT |
9 |
0.0001 |
| 849 |
HEADACHE |
92 |
0.0001 |
| 850 |
RASH ERYTHEMATOUS |
7 |
0.0001 |
| 851 |
HOT FLUSH |
11 |
0.0001 |
| 852 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
7 |
0.0001 |
| 853 |
GASTRIC DISORDER |
5 |
0.0001 |
| 854 |
HAEMOPTYSIS |
4 |
0.0001 |
| 855 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
29 |
0.0001 |
| 856 |
WITHDRAWAL SYNDROME |
6 |
0.0001 |
| 857 |
BURNING SENSATION |
10 |
0.0001 |
| 858 |
DEATH |
122 |
0.0001 |
| 859 |
PRODUCT DOSE OMISSION IN ERROR |
4 |
0.0001 |
| 860 |
LYMPHADENOPATHY |
5 |
0.0001 |
| 861 |
PAIN IN JAW |
4 |
0.0001 |
| 862 |
JOINT INJURY |
3 |
0.0001 |
| 863 |
HYPOAESTHESIA |
21 |
0.0001 |
| 864 |
THERAPY INTERRUPTED |
10 |
0.0001 |
| 865 |
IRRITABLE BOWEL SYNDROME |
3 |
0.0001 |
| 866 |
CEREBRAL HAEMORRHAGE |
5 |
0.0001 |
| 867 |
SWELLING |
13 |
0.0001 |
| 868 |
SWELLING FACE |
9 |
0.0001 |
| 869 |
LIVER FUNCTION TEST ABNORMAL |
4 |
0.0001 |
| 870 |
ACUTE KIDNEY INJURY |
21 |
0.0001 |
| 871 |
DYSSTASIA |
4 |
0.0001 |
| 872 |
BONE PAIN |
8 |
0.0001 |
| 873 |
DIZZINESS |
68 |
0.0001 |
| 874 |
INFUSION RELATED REACTION |
9 |
0.0001 |
| 875 |
CHEST PAIN |
25 |
0.0001 |
| 876 |
STEVENS-JOHNSON SYNDROME |
3 |
0.0001 |
| 877 |
WHEEZING |
8 |
0.0001 |
| 878 |
DYSGEUSIA |
10 |
0.0001 |
| 879 |
CATARACT |
8 |
0.0001 |
| 880 |
THROAT IRRITATION |
6 |
0.0001 |
| 881 |
FEELING ABNORMAL |
32 |
0.0001 |
| 882 |
THERAPY NON-RESPONDER |
6 |
0.0001 |
| 883 |
NO ADVERSE EVENT |
24 |
0.0001 |
| 884 |
ACNE |
10 |
0.0001 |
| 885 |
DIABETES MELLITUS |
10 |
0.0001 |
| 886 |
TINNITUS |
6 |
0.0001 |
| 887 |
SKIN DISCOLOURATION |
6 |
0.0001 |
| 888 |
DRUG ADMINISTRATION ERROR |
4 |
0.0001 |
| 889 |
HYPERSENSITIVITY |
24 |
0.0001 |
| 890 |
RENAL DISORDER |
6 |
0.0001 |
| 891 |
PALPITATIONS |
15 |
0.0001 |
| 892 |
ANAPHYLACTIC REACTION |
7 |
0.0001 |
| 893 |
BLISTER |
7 |
0.0001 |
| 894 |
CONFUSIONAL STATE |
20 |
0.0001 |
| 895 |
EXTRA DOSE ADMINISTERED |
5 |
0.0001 |
| 896 |
MATERNAL EXPOSURE DURING PREGNANCY |
11 |
0.0001 |
| 897 |
ATRIAL FIBRILLATION |
12 |
0.0001 |
| 898 |
BLINDNESS |
5 |
0.0001 |
| 899 |
DEVICE ISSUE |
11 |
0.0001 |
| 900 |
OSTEONECROSIS |
4 |
0.0001 |
| 901 |
SKIN DISORDER |
4 |
0.0001 |
| 902 |
UNEVALUABLE EVENT |
9 |
0.0001 |
| 903 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
3 |
0.0001 |
| 904 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 905 |
FLUID RETENTION |
6 |
0.0001 |
| 906 |
MULTIPLE SCLEROSIS RELAPSE |
8 |
0.0001 |
| 907 |
HYPERHIDROSIS |
15 |
0.0001 |
| 908 |
SKIN ULCER |
3 |
0.0001 |
| 909 |
DRUG DOSE OMISSION BY DEVICE |
9 |
0.0001 |
| 910 |
HAEMORRHAGE |
12 |
0.0001 |
| 911 |
ANHEDONIA |
3 |
0.0001 |
| 912 |
DEPRESSED MOOD |
6 |
0.0001 |
| 913 |
BRADYCARDIA |
6 |
0.0001 |
| 914 |
ANGIOEDEMA |
5 |
0.0001 |
| 915 |
MALAISE |
49 |
0.0001 |
| 916 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
5 |
0.0001 |
| 917 |
MOBILITY DECREASED |
8 |
0.0001 |
| 918 |
DRY MOUTH |
9 |
0.0001 |
| 919 |
INCORRECT DOSE ADMINISTERED |
25 |
0.0001 |
| 920 |
SKIN LESION |
3 |
0.0001 |
| 921 |
SKIN IRRITATION |
5 |
0.0001 |
| 922 |
PAIN IN EXTREMITY |
32 |
0.0001 |
| 923 |
FLUSHING |
11 |
0.0001 |
| 924 |
FEELING COLD |
3 |
0.0001 |
| 925 |
URTICARIA |
18 |
0.0001 |
| 926 |
WOUND |
3 |
0.0001 |
| 927 |
CARDIAC DISORDER |
10 |
0.0001 |
| 928 |
TARDIVE DYSKINESIA |
3 |
0.0001 |
| 929 |
HALLUCINATION |
8 |
0.0001 |
| 930 |
PRURITUS |
40 |
0.0001 |
| 931 |
CHILLS |
12 |
0.0001 |
| 932 |
ERYTHEMA |
21 |
0.0001 |
| 933 |
RENAL INJURY |
3 |
0.0001 |
| 934 |
PREMATURE BABY |
3 |
0.0001 |
| 935 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
7 |
0.0001 |
| 936 |
THERAPY CESSATION |
5 |
0.0001 |
| 937 |
DEPRESSION |
22 |
0.0001 |
| 938 |
SWOLLEN TONGUE |
3 |
0.0001 |
| 939 |
ROAD TRAFFIC ACCIDENT |
4 |
0.0001 |
| 940 |
ECZEMA |
5 |
0.0001 |
| 941 |
CYSTITIS |
3 |
0.0001 |
| 942 |
NIGHT SWEATS |
3 |
0.0001 |
| 943 |
HYPOACUSIS |
4 |
0.0001 |
| 944 |
DEVICE LEAKAGE |
4 |
0.0001 |
| 945 |
INTENTIONAL PRODUCT USE ISSUE |
8 |
0.0001 |
| 946 |
THERAPEUTIC RESPONSE SHORTENED |
3 |
0.0001 |
| 947 |
ARTHROPATHY |
5 |
0.0001 |
| 948 |
PRODUCT QUALITY ISSUE |
12 |
0.0001 |
| 949 |
LOWER RESPIRATORY TRACT INFECTION |
4 |
0.0001 |
| 950 |
ALOPECIA |
17 |
0.0001 |
| 951 |
PAIN |
53 |
0.0001 |
| 952 |
NEOPLASM PROGRESSION |
3 |
0.0001 |
| 953 |
BACK PAIN |
20 |
0.0001 |
| 954 |
DYSPHONIA |
5 |
0.0001 |
| 955 |
DEVICE MALFUNCTION |
6 |
0.0001 |
| 956 |
MULTIPLE SCLEROSIS |
4 |
0.0001 |
| 957 |
CEREBROVASCULAR ACCIDENT |
14 |
0.0001 |
| 958 |
EMOTIONAL DISTRESS |
10 |
0.0001 |
| 959 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
3 |
0.0001 |
| 960 |
VERTIGO |
5 |
0.0001 |
| 961 |
ARTHRALGIA |
34 |
0.0001 |
| 962 |
DYSARTHRIA |
3 |
0.0001 |
| 963 |
INJECTION SITE SWELLING |
6 |
0.0001 |
| 964 |
MALIGNANT NEOPLASM PROGRESSION |
8 |
0.0001 |
| 965 |
INTENTIONAL OVERDOSE |
5 |
0.0001 |
| 966 |
AMNESIA |
5 |
0.0001 |
| 967 |
SUICIDAL IDEATION |
7 |
0.0001 |
| 968 |
DRY SKIN |
10 |
0.0001 |
| 969 |
JOINT SWELLING |
9 |
0.0001 |
| 970 |
PSORIATIC ARTHROPATHY |
3 |
0.0001 |
| 971 |
VISION BLURRED |
10 |
0.0001 |
| 972 |
VISUAL IMPAIRMENT |
9 |
0.0001 |
| 973 |
DRUG DOSE OMISSION |
12 |
0.0001 |
| 974 |
DYSPEPSIA |
7 |
0.0001 |
| 975 |
INJURY |
5 |
0.0001 |
| 976 |
OSTEOARTHRITIS |
3 |
0.0001 |
| 977 |
HERPES ZOSTER |
4 |
0.0001 |
| 978 |
VAGINAL HAEMORRHAGE |
3 |
0.0001 |
| 979 |
DEVICE DISLOCATION |
3 |
0.0001 |
| 980 |
MYOCARDIAL INFARCTION |
12 |
0.0001 |
| 981 |
EXPOSURE DURING PREGNANCY |
4 |
0.0001 |
| 982 |
INTERSTITIAL LUNG DISEASE |
3 |
0.0001 |
| 983 |
ASTHMA |
6 |
0.0001 |
| 984 |
ARTHRITIS |
4 |
0.0001 |
| 985 |
INJECTION SITE BRUISING |
4 |
0.0001 |
| 986 |
INJECTION SITE ERYTHEMA |
6 |
0.0000 |
| 987 |
SKIN EXFOLIATION |
4 |
0.0000 |
| 988 |
PSORIASIS |
6 |
0.0000 |
| 989 |
DRUG WITHDRAWAL SYNDROME |
4 |
0.0000 |
| 990 |
INJECTION SITE PRURITUS |
3 |
0.0000 |
| 991 |
INJECTION SITE HAEMORRHAGE |
3 |
0.0000 |
| 992 |
PROSTATE CANCER |
3 |
0.0000 |
| 993 |
FOETAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 994 |
INJECTION SITE PAIN |
8 |
0.0000 |